| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8605038 | The Journal of Pain | 2018 | 9 Pages |
Abstract
This study suggests that ketamine antinociception depends at least in part on AEA release and CB1 cannabinoid receptor activation in inflammatory conditions. This study could potentially help clinicians in the use of ketamine as a peripheral analgesic for inflammatory pain.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Renata C.M. Ferreira, Marina G.M. Castor, Fabiana Piscitelli, Vincenzo Di Marzo, Igor D.G. Duarte, Thiago R.L. Romero,